Related references
Note: Only part of the references are listed.Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors
Jacklynn M. Fitzgerald et al.
NEUROBIOLOGY OF STRESS (2021)
Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis
Mikkel Carstensen et al.
IMMUNOLOGY AND CELL BIOLOGY (2020)
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages
John-Mark Fitzpatrick et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
Impact of short-term cycle ergometer training on quality of life, cognition and depressive symptomatology in multiple sclerosis patients: a pilot study
Alison Barry et al.
NEUROLOGICAL SCIENCES (2018)
Cannabidiol restores differentiation capacity of LPS exposed adipose tissue mesenchymal stromal cells
Tim Ruhl et al.
EXPERIMENTAL CELL RESEARCH (2018)
Interferon-1a and-1b for patients with multiple sclerosis: updates to current knowledge
Uwe Klaus Zettl et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)
Type 1 IFN Induction by Cytosolic Nucleic Acid Is Intact in Neonatal Mononuclear Cells, Contrasting Starkly with Neonatal Hyporesponsiveness to TLR Ligation Due to Independence from Endosome-Mediated IRF3 Activation
Kiva Brennan et al.
JOURNAL OF IMMUNOLOGY (2018)
Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia
Sinead A. O'Sullivan et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis
Stefania Petrosino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Antidepressants Improve Negative Regulation of Toll-Like Receptor Signaling in Monocytes from Patients with Major Depression
Yi-Yung Hung
NEUROIMMUNOMODULATION (2018)
Type I interferon pathway in CNS homeostasis and neurological disorders
Thomas Blank et al.
GLIA (2017)
Raf Kinase Inhibitor Protein Preferentially Promotes TLR3-Triggered Signaling and Inflammation
Rongrong Lai et al.
JOURNAL OF IMMUNOLOGY (2017)
Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis
John-Mark K. Fitzpatrick et al.
NEUROPHARMACOLOGY (2017)
Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model
Ashleigh L. Osborne et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Early diagnosis of bacterial infection in patients with septicopyemia by laboratory analysis of PCT, CRP and IL-6
Liqin Gao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Delta(9)-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats
Rebecca K. Vella et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons
Shanshan Sun et al.
REDOX BIOLOGY (2017)
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
Arianna Bettiga et al.
SCIENTIFIC REPORTS (2017)
PKC-epsilon and TLR4 synergistically regulate resistin-mediated inflammation in human macrophages
Mary C. Zuniga et al.
ATHEROSCLEROSIS (2017)
Δ9-Tetrahydrocannabinol reverses TNFα-induced increase in airway epithelial cell permeability through CB2 receptors
Valerie C. M. Shang et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages
Thangavelu Soundara Rajan et al.
FITOTERAPIA (2016)
Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages
Barbara Romano et al.
PHARMACOLOGICAL RESEARCH (2016)
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia
F. F. Peres et al.
SCHIZOPHRENIA RESEARCH (2016)
Δ9Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells
R. Rao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
A. Feliu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Peripheral Blood Cells from Patients with Autoimmune Addison's Disease Poorly Respond to Interferons In Vitro, Despite Elevated Serum Levels of Interferon-Inducible Chemokines
Kine Edvardsen et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Role of the innate and adaptive immune responses in the course of multiple sclerosis
Bernhard Hemmer et al.
LANCET NEUROLOGY (2015)
Long-term effects of fingolimod in multiple sclerosis The randomized FREEDOMS extension trial
Ludwig Kappos et al.
NEUROLOGY (2015)
Molecular Targets of Cannabidiol in Neurological Disorders
Clementino Ibeas Bih et al.
NEUROTHERAPEUTICS (2015)
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis
Tadhg Crowley et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires
Anja Fischer et al.
BRAIN AND BEHAVIOR (2015)
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis
Robert J. Simpson et al.
BMC NEUROLOGY (2014)
Interferon regulatory factor (IRF) 3 is critical for the development of experimental autoimmune encephalomyelitis
Denise C. Fitzgerald et al.
JOURNAL OF NEUROINFLAMMATION (2014)
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis
Reza Vazirinejad et al.
NEUROIMMUNOMODULATION (2014)
Distinct Modulation of Human Myeloid and Plasmacytoid Dendritic Cells by Anandamide in Multiple Sclerosis
Valerio Chiurchiu et al.
ANNALS OF NEUROLOGY (2013)
Inflammatory Chemokine Expression via Toll-Like Receptor 3 Signaling in Normal Human Mesangial Cells
Hiroshi Tanaka et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
Abdolmohamad Rostami et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ9-tetrahydrocannabinol in human CD4+ T cells
Thitirat Ngaotepprutaram et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The Synthetic Cannabinoid R(+)WIN55,212-2 Augments Interferon-β Expression via Peroxisome Proliferator-activated Receptor-α
Eric J. Downer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis
Silvia Rossi et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Evaluation of Serum Levels of Chemokines during Interferon-β Treatment in Multiple Sclerosis Patients
Elizabeth R. Comini-Frota et al.
CNS DRUGS (2011)
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
Mingli Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients
George P. Christophi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation
Eric J. Downer
THESCIENTIFICWORLDJOURNAL (2011)
Cannabidiol Induces Intracellular Calcium Elevation and Cytotoxicity in Oligodendrocytes
Susana Mato et al.
GLIA (2010)
Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
Ewa Kozela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The role of dendritic cells in CNS autoimmunity
Alla L. Zozulya et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Role of the innate immune system in the pathogenesis of multiple sclerosis
Roopali Gandhi et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Interferon-β is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis
C. L. Galligan et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Toll-like Receptors in Multiple Sclerosis Mouse Experimental Models
Monica Marta
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Plasma endocannabinoid levels in multiple sclerosis
L. Jean-Gilles et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Toll-like Receptor and RIG-1-like Receptor Signaling
Taro Kawai et al.
YEAR IN IMMUNOLOGY 2008 (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Role of the innate immune system in autoimmune inflammatory demyelination
Kate O'Brien et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis
Monica Marta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
The CB2 cannabinoid receptor controls myeloid progenitor trafficking
Javier Palazuelos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Beichu Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
TLR-activated B cells suppress T cell-mediated autoimmunity
Vicky Lampropoulou et al.
JOURNAL OF IMMUNOLOGY (2008)
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
Asa Andersson et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
The endocannabinoid system modulates a transient TNF pathway that induces neural stem cell proliferation
Ana Rubio-Araiz et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Enhancing the in vitro cytotoxic activity of Delta(9)-tetrahydrocannabinol in leukemic cells through a combinatorial approach
Wai M. Liu et al.
LEUKEMIA & LYMPHOMA (2008)
Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors
G. Pryce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
Diego Centonze et al.
BRAIN (2007)
Toll-like receptors and type I interferons
Satoshi Uematsu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Systemic infections and inflammation affect chronic neurodegeneration
V. Hugh Perry et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor
Steven W. Paugh et al.
MOLECULAR PHARMACOLOGY (2006)
Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNβ-responsive genes in peripheral blood lymphocytes in vitro:: an implication for IFNβ-related adverse effects in multiple sclerosis
Jun-ichi Satoh et al.
BMC NEUROLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
M Prinz et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Tissue-specific mRNA expression profiles of human toll-like receptors and related genes
M Nishimura et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon β and copolymer-1
A Prat et al.
JOURNAL OF AUTOIMMUNITY (2005)
Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-κB-dependent apoptosis:: Novel role for endogenous and exogenous cannabinoids in immunoregulation
Y Do et al.
JOURNAL OF IMMUNOLOGY (2004)
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
G Pryce et al.
BRAIN (2003)
Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons
EJ Downer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes
BLF Kaplan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Quality of life in patients with multiple sclerosis: The impact of fatigue and depression
V Janardhan et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2002)
Broad expression of Toll-like receptors in the human central nervous system
M Bsibsi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Δ9-tetrahydrocannabinol and cannabinol activate capsaicin-sensitive sensory nerves via a CB1 and CB2 cannabinoid receptor-independent mechanism
PM Zygmunt et al.
JOURNAL OF NEUROSCIENCE (2002)
Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
V Hornung et al.
JOURNAL OF IMMUNOLOGY (2002)
Δ9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor
E Downer et al.
NEUROREPORT (2001)
Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-β) treatment
V Özenci et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Share Paper
